IMARC Group, a leading market research company, has recently releases report titled “U.S. Ketamine Clinics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the U.S. ketamine clinics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How Big Is the U.S. Ketamine Clinics Market?
The U.S. ketamine clinics market size reached US$ 3.24 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.91 Billion by 2028, exhibiting a growth rate (CAGR) of 10.60% during 2023-2028.
Industry Overview of U.S. Ketamine Clinics Market
Ketamine clinics are healthcare facilities staffed by trained professionals who offer supervised and controlled ketamine infusion therapy. These clinics come in various forms, including standalone centers dedicated exclusively to ketamine infusion therapy and specialized units within existing medical institutions. Their primary focus is on the therapeutic use of ketamine, a dissociative anesthetic and analgesic, to address treatment-resistant conditions such as depression, anxiety, and other mood disorders. They employ intravenous (IV) infusion methods, carefully monitoring and administering ketamine over a specified timeframe. As they provide effective solutions for individuals grappling with severe and treatment-resistant mental health conditions, their demand is on the rise in the United States.
U.S. Ketamine Clinics Market Trends and Drivers:
Currently, the market in the United States is experiencing significant growth, driven by several key factors. Firstly, the increasing popularity of ketamine is noteworthy, as it delivers rapid results, unlike traditional antidepressant medications that require an extended period to take effect. This characteristic is a crucial driver of market expansion. Moreover, there is a rising public awareness regarding mental health issues, coupled with a growing inclination toward seeking alternative and innovative treatments. This trend is further fueling market growth in the country. Additionally, the proliferation of clinics that offer a controlled and medically supervised environment for administering ketamine infusions is contributing to a positive market outlook in the United States. Furthermore, the increasing incidence of conditions such as bipolar disorder, anxiety, and post-traumatic stress disorder (PTSD) among individuals, often attributed to excessive work pressures, is boosting market growth in the United States.
What Is Included In Market Segmentation?
The report has segmented the market into the following categories:
Breakup by Treatment:
- Depression
- Anxiety
- PTSD
- Others
Breakup by Therapy:
- On-Site Therapy
- Online Therapy
Breakup by Region:
- Northeast
- Midwest
- South
- West
The report provides a comprehensive analysis of the industry key players listed below:
Better U LLC, Field Trip Health and Wellness Ltd., Innerwell, Ketamine Clinics Los Angeles, Klarisana – Ketamine Treatment Austin, Klarity Clinic, Mindbloom Inc., Nue Life Health PBC, NY Ketamine Infusions, Vitalitas Denver.